摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-甲基-3-硝基-5-溴苯甲酸 | 107650-20-4

中文名称
2-甲基-3-硝基-5-溴苯甲酸
中文别名
5-溴-2-甲基-3-硝基苯甲酸;5-溴-3-硝基-2-甲基苯甲酸
英文名称
5-bromo-2-methyl-3-nitrobenzoic acid
英文别名
——
2-甲基-3-硝基-5-溴苯甲酸化学式
CAS
107650-20-4
化学式
C8H6BrNO4
mdl
MFCD07357316
分子量
260.044
InChiKey
DXUUJILVHXQDCV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    377.0±42.0 °C(Predicted)
  • 密度:
    1.777±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.125
  • 拓扑面积:
    83.1
  • 氢给体数:
    1
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2916399090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    室温且干燥环境下使用。

SDS

SDS:b44085e9463393bde5282fafe9507ac1
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 5-Bromo-2-methyl-3-nitrobenzoic acid
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 5-Bromo-2-methyl-3-nitrobenzoic acid
CAS number: 107650-20-4

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H6BrNO4
Molecular weight: 260.0

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3
    • 4

反应信息

  • 作为反应物:
    参考文献:
    名称:
    [EN] Crystalline forms of [1,1'-Biphenyl]-3-carboxamide, N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-5-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-4-methyl-4'-(4-morpholinylmethyl)-, hydrobromide (1:1) and process for its preparation thereof
    [FR] FORMES CRISTALLINES DU [1,1'-BIPHÉNYL]-3-CARBOXAMIDE, N-[(1,2-DIHYDRO-4,6-DIMÉTHYL-2-OXO-3-PYRIDINYL)MÉTHYL]-5-[ÉTHYL(TÉTRAHYDRO-2H-PYRAN-4-YL)AMINO]-4-MÉTHYL-4'-(4-MORPHOLINYLMÉTHYL)-, BROMHYDRATE (1:1) ET SON PROCÉDÉ DE PRÉPARATION
    摘要:
    [1,1'-联苯]-3-羧酰胺,N-[(1,2-二氢-4,6-二甲基-2-氧-3-吡啶基)甲基]-5-[乙基(四氢-2H-吡喃-4-基)氨基]-4-甲基-4'-(4-吗啡啉基甲基)-,溴化氢盐(1:1)的晶型及其制备方法。本发明涉及由以下结构式-1表示的[1,1'-联苯]-3-羧酰胺,N-[(1,2-二氢-4,6-二甲基-2-氧-3-吡啶基)甲基]-5-[乙基(四氢-2H-吡喃-4-基)氨基]-4-甲基-4'-(4-吗啡啉基甲基)-,溴化氢盐(1:1)的晶型及其制备方法。
    公开号:
    WO2022208552A1
  • 作为产物:
    描述:
    2-甲基-3-硝基苯甲酸1,3-二溴-5,5-二甲基海因硫酸 作用下, 反应 5.0h, 以100%的产率得到2-甲基-3-硝基-5-溴苯甲酸
    参考文献:
    名称:
    (E)-1,2-二苯乙烯基EZH2抑制剂的设计与合成。
    摘要:
    zeste同源物2(EZH2)的增强子是多梳抑制复合物2(PRC2)的催化亚基,与癌症进展转移和不良预后有关。基于具有低纳摩尔活性的EZH2抑制剂SKLB1049,我们扩展了“尾巴”区域,获得了一系列作为新型EZH2抑制剂的(E)-1,2-二苯乙烯衍生物。SAR探索和初步评估导致发现了有效的新型EZH2抑制剂9b(EZH2WT IC50 = 22.0 nM)。化合物9b抑制WSU-DLCL2和SU-DHL-4细胞系的增殖(IC50分别为1.61 µM和2.34 µM)。生物学评估表明,9b是野生型EZH2的有效抑制剂,并以浓度依赖的方式大大降低了H3K27me3的总体水平。进一步的研究表明9b可以显着诱导SU-DHL-4细胞凋亡。这些发现表明9b将是用于进一步优化和评估的有吸引力的先导化合物。
    DOI:
    10.1016/j.bmcl.2020.126957
  • 作为试剂:
    描述:
    1,3-二溴-5,5-二甲基海因2-甲基-3-硝基苯甲酸 在 ice 、 2-甲基-3-硝基-5-溴苯甲酸 作用下, 以 硫酸 为溶剂, 反应 5.0h, 以giving the desired compound, 5-bromo-2-methyl-3-nitrobenzoic acid (71.7 g, 99.9%) which的产率得到2-甲基-3-硝基-5-溴苯甲酸
    参考文献:
    名称:
    Aryl- or heteroaryl-substituted benzene compounds
    摘要:
    本发明涉及芳基或杂环芳基取代的苯化合物。本发明还涉及包含这些化合物的制药组合物以及通过将这些化合物和制药组合物用于需要这些化合物的受试者治疗癌症的方法。本发明还涉及将这些化合物用于研究或其他非治疗目的的用途。
    公开号:
    US09090562B2
点击查看最新优质反应信息

文献信息

  • [EN] NOVEL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS
    申请人:GLAXOSMITHKLINE IP DEV LTD
    公开号:WO2015180612A1
    公开(公告)日:2015-12-03
    Disclosed are novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.
    揭示了新型视黄醇相关孤儿受体γ(RORγ)调节剂及其在通过RORγ介导的疾病治疗中的应用。
  • HISTONE METHYLTRANSFERASE EZH2 INHIBITOR, PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF
    申请人:ANCUREALL PHARMACEUTICAL (SHANGHAI) CO., LTD.
    公开号:US20190345139A1
    公开(公告)日:2019-11-14
    The invention relates to a histone methyltransferase EZH2 inhibitor, a preparation method and pharmaceutical use thereof. In particular, the invention relates to a compound represented by the general formula (I), a preparation method thereof, a pharmaceutical composition containing the same, and a use thereof as a histone methyltransferase EZH2 inhibitor for treating diseases associated with the histone methyltransferase EZH2, especially cancer. The definition of each substituents in the general formula (I) is same as the definition in the specification.
    这项发明涉及一种组蛋白甲基转移酶EZH2抑制剂,其制备方法和药用。具体而言,该发明涉及一种由通式(I)表示的化合物,其制备方法,含有该化合物的药物组合物,以及将其用作组蛋白甲基转移酶EZH2抑制剂治疗与组蛋白甲基转移酶EZH2相关的疾病,特别是癌症。通式(I)中每个取代基的定义与规范中的定义相同。
  • 一种取代硝基苯类化合物的制备方法
    申请人:联化科技股份有限公司
    公开号:CN109467509B
    公开(公告)日:2021-09-24
    本发明公开了一种取代硝基苯类化合物的制备方法。该方法包括下述步骤:溶剂中,在150℃~250℃的温度下,化合物II在碱的作用下进行如下所示的脱羧反应得到化合物I即可;所述的碱为碱属的碳酸盐和碳酸氢盐中的一种或多种。该方法相比一些使用属催化的脱羧方法,具有操作简单、生产成本低、后处理方便、收率高的优点,在工业化生产中更具有应用价值。
  • [EN] EZH2 INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE EZH2 ET LEURS UTILISATIONS
    申请人:PIRAMAL ENTPR LTD
    公开号:WO2015110999A1
    公开(公告)日:2015-07-30
    The present invention provides compound of formula 1, or an isotopic form, a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a solvate, a polymorph, a prodrug, S-oxide or N-oxide thereof. The invention also relates toprocesses for their preparation, to pharmaceutical compositions containing them and use of the compound of formula 1, in the treatment of diseases or disorders mediated by EZH2 (enhancer of zeste homolog 2), particularly cancer.
    本发明提供了式1的化合物,或其同位素形式、立体异构体、互变异构体、药学上可接受的盐、溶剂合物、多晶形态、前药、其S-氧化物或N-氧化物。该发明还涉及它们的制备方法,含有它们的药物组合物以及利用式1的化合物治疗由EZH2(增强子齐斯特同源物2)介导的疾病或紊乱。
  • Pyranouidole Derivatives and the Use Thereof for the Treatment of Hepatitis C Virus Infection or Disease
    申请人:Condon M. Stephen
    公开号:US20070219212A1
    公开(公告)日:2007-09-20
    The invention is directed to novel pyranoindole derivatives and analogs as well as compositions containing the same and to the use thereof for the treatment, prevention or inhibition of viral infections and associated diseases caused by the Hepatitis C virus.
    这项发明涉及新型吲哚生物和类似物,以及含有这些物质的组合物,以及将其用于治疗、预防或抑制由丙型肝炎病毒引起的病毒感染和相关疾病的用途。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫